Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-22-016537

President and CEO sold 2,493 shares at $112.26 ($279,852)

  • President and CEO acquired 40,990 shares (grant or award)
  • President and CEO acquired 7,848 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LEONARD JOHN M · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-01 Exercise or conversion : show line 1 in the form +7,848 727,153 D
2022-01-01 Sale : show line 2 in the form −2,493 $112.26 $279,852 724,660 D
2022-03-01 Grant or award : show line 3 in the form +40,990 765,650 D
Open-market sales · 2,493 sh · avg $112.26 · $279,852

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-01-01 Exercise or conversion : show line 4 in the form Restricted Stock Unit −7,848 23,546 D
2022-03-01 Grant or award : show line 5 in the form Stock Option (right to buy) +59,941 59,941 D
Loading xslF345X03/doc4.xml…